openPR Logo
Press release

Polymyalgia Rheumatica Treatment Market Size, Share, Growth, Analysis, Report and Forecast 2024-2032

01-12-2024 06:25 AM CET | Health & Medicine

Press release from: Expert Market Research

Polymyalgia Rheumatica Treatment Market

Polymyalgia Rheumatica Treatment Market

Polymyalgia Rheumatica Treatment Market Outlook

According to the report by Expert Market Research (EMR), the global polymyalgia rheumatica treatment market size is projected to grow at a CAGR of 4.7% between 2024 and 2032. Aided by the increasing focus on personalised medicine, the market is expected to grow significantly by 2032.

Polymyalgia rheumatica is an inflammatory disorder typically affecting adults over the age of 50. It is characterised by muscle pain and stiffness, particularly in the shoulders, neck, and hips. The precise cause of PMR is unknown, but it is believed to be related to autoimmune reactions and genetic factors.

The global polymyalgia rheumatica treatment market demand is primarily driven by the increasing prevalence of this condition, particularly among the aging population. The rise in the elderly population, who are more susceptible to such inflammatory diseases, is a key factor contributing to the market growth. Furthermore, advancements in medical research and diagnostics are enabling better identification and treatment of PMR, further fuelling market expansion.

Get a Free Sample Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market/requestsample

The primary treatment for polymyalgia rheumatica involves corticosteroids, which are effective in reducing inflammation and pain. The market for PMR treatment includes a range of corticosteroids, with prednisone being the most commonly prescribed medication. However, long-term use of corticosteroids is associated with potential side effects, leading to the demand for safer and more effective treatment options.

Biologic therapies are account for a significant portion of the polymyalgia rheumatica treatment market share. These therapies, which include tumour necrosis factor (TNF) inhibitors and interleukin-6 (IL-6) receptor blockers, offer targeted treatment and are often used in patients who do not respond adequately to corticosteroids. The development and approval of new biologic agents are expected to provide impetus to the market growth.

One of the key polymyalgia rheumatica treatment market trends is the growing focus on personalised medicine. Understanding the genetic and environmental factors contributing to PMR is leading to more tailored treatment approaches, improving patient outcomes and treatment efficacy.

Read Full Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market

The market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe are leading markets due to the high prevalence of PMR, well-established healthcare systems, and the presence of key pharmaceutical companies engaged in PMR research. The Asia Pacific region is also witnessing growth, driven by increasing awareness and improving healthcare infrastructure.

Polymyalgia Rheumatica Treatment Market Segmentation

The market can be divided based on diagnostic method, drug class, route of administration, end use, and region.

Market Breakup by Diagnostic Method

Blood Tests
Imaging Tests

Market Breakup by Drug Class

Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Nonsteroidal Anti-Inflammatory Drugs
Others

Market Breakup by Route of Administration

Oral
Parenteral

Market Breakup by End Use

Hospitals
Homecare
Speciality Clinics
Others

Market Breakup by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global polymyalgia rheumatica treatment market. Some of the major players explored in the report by Expert Market Research are as follows:

Sanofi SA
Apotex Corporation
GlaxoSmithKline plc
AbbVie Inc.
Horizon Therapeutics plc
Others

Read More Reports

GNSS Simulators Market: https://www.expertmarketresearch.com/reports/gncc-simulators-market

Electric Scooter and Motorcycle Market: https://www.expertmarketresearch.com/reports/electric-scooter-and-motorcycle-market

Electric Mop Market: https://www.expertmarketresearch.com/reports/electric-mop-market

Electric Drives Market: https://www.expertmarketresearch.com/reports/electric-drives-market

Cristobalite Market: https://www.expertmarketresearch.com/reports/cristobalite-market

Bio-Based Platform Chemicals Market: https://www.expertmarketresearch.com/reports/bio-based-platform-chemicals-market

Media Contact

Company Name: Claight Corporation
Contact Person: Christopher, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polymyalgia Rheumatica Treatment Market Size, Share, Growth, Analysis, Report and Forecast 2024-2032 here

News-ID: 3350086 • Views:

More Releases from Expert Market Research

United States Webcam Market Size, Growth & Trends 2025-2034
United States Webcam Market Size, Growth & Trends 2025-2034
The United States webcam market has experienced substantial growth in recent years, fueled by the increasing demand for high-quality video communication tools. Webcams, which were once primarily used for video conferencing, have become essential for various applications, including content creation, gaming, online education, and telehealth. The widespread adoption of remote work and digital learning has further accelerated the growth of this market. In 2024, the U.S. webcam market was valued at
Precision Medicine Market: A Deep Dive into Its Evolving Landscape
Precision Medicine Market: A Deep Dive into Its Evolving Landscape
The precision medicine market represents one of the most transformative shifts in modern healthcare. Instead of relying on generalized treatments that assume all patients respond similarly, precision medicine leverages biological, genetic, and lifestyle data to deliver interventions tailored to the individual. This personalized approach is reshaping how diseases are prevented, diagnosed, and managed. Its importance continues to grow as healthcare systems seek more efficient, patient-centered solutions capable of improving outcomes
Global Industrial Hemp Market: Growth, Trends, and Future Outlook 2034
Global Industrial Hemp Market: Growth, Trends, and Future Outlook 2034
The global industrial hemp market is on a rapid growth trajectory. In 2024, the market size is expected to reach approximately USD 5.99 billion, and it's projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period from 2025 to 2034. By 2034, the market is set to reach an impressive value of USD 34.16 billion. This growth is driven by the increasing demand for
Laboratory Information System Market Hits $2.1B, 9% CAGR
Laboratory Information System Market Hits $2.1B, 9% CAGR
Why Is the Laboratory Information System Market Growing So Rapidly in 2024-2034? The laboratory information system market is undergoing significant expansion due to increasing digitalization in healthcare and growing demand for efficient diagnostic workflow management. As laboratories face rising testing volumes, stricter regulatory requirements, and a growing need for automated sample tracking, the adoption of LIS platforms has accelerated globally. In 2024, the market reached USD 2.10 Billion, and with a robust

All 5 Releases


More Releases for Polymyalgia

Polymyalgia Rheumatica Market Trends, Treatment Advances, and Growth Opportuniti …
Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder primarily affecting adults over 50, characterized by muscle pain and stiffness, particularly in the shoulders and hips. The disease significantly impacts quality of life and daily functioning, making timely diagnosis and effective treatment essential. With an aging global population and growing awareness of inflammatory conditions, the Polymyalgia Rheumatica market is poised for substantial growth, driven by advancements in therapeutics, diagnostic capabilities, and
Polymyalgia Rheumatica Market to Hit $322.49 Mn by 2034
The global healthcare industry is increasingly focused on addressing chronic inflammatory conditions, among which polymyalgia rheumatica (PMR) holds a distinct place. Primarily affecting individuals over the age of 50, PMR is characterized by pain and stiffness in the shoulders and hips, often linked to systemic inflammation. According to Expert Market Research, the global polymyalgia rheumatica treatment market attained a value of USD 203.73 million in 2024 and is expected to
Polymyalgia Rheumatica Treatment Market would grow upto USD 513.47 million by 20 …
The global polymyalgia rheumatica treatment market is expected to witness significant growth during the forecast period. This disorder mainly occurs in ageing people aged above 60 years. It is more dominant in females than males, with a ratio of 2:1. Polymyalgia rheumatica is an autoimmune disease with no identified cause, however its been suggested that there is a link between genetic and environmental factors leading to the spread of this
Polymyalgia Rheumatica Market Expected to Reach US$ 9,623.4 Million by 2033 | IM …
The newly published report by IMARC Group, titled "Polymyalgia Rheumatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the polymyalgia rheumatica market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and
Polymyalgia Rheumatica Market - Empowering Comfort, Embracing Movement: Polymyal …
Newark, New Castle, USA: The "Polymyalgia Rheumatica Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Polymyalgia Rheumatica Market: https://www.growthplusreports.com/report/polymyalgia-rheumatica-market/8813 This latest report researches the industry structure, sales, revenue,
Polymyalgia Rheumatica Market Report, History and Forecast 2021-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Polymyalgia Rheumatica Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Polymyalgia Rheumatica provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive